2m 2m 2m 2m 2m 2m 2m
Vireo Growth (VREOF)
OTC
$8.51-$0.40 (-4.49%)
Price as of Oct 22, 2026- $438.6MMarket Cap
- -54.97%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Vireo Growth (VREOF)
$8.51-$0.40 (-4.49%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 268.8M +170.43% | 99.4M +12.77% | 88.1M +18.10% | 74.6M +37.06% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | 39.4M +23.18% | |
Gross Profit | 127.1M +150.33% | 50.8M +15.12% | 44.1M +42.69% | 30.9M +56.11% | |
Sales and Marketing Expense | 81.2M +189.30% | 28.1M -0.55% | 28.2M -16.57% | 33.8M +0.50% | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 5.7M +698.14% | 720,134 +6.08% | 678,861 +0.34% | 676,566 -17.21% | |
Total Operating Expenses | 128.1M +244.40% | 37.2M +10.99% | 33.5M -11.42% | 37.8M -6.04% | |
Operating Profit | -1.0M -107.73% | 13.6M +28.20% | 10.6M +252.46% | -6.9M -66.12% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -15.9M N/A | N/A N/A | -31.3M +38.36% | -22.6M +113.64% | |
Interest Income and Expense and Net | -15.9M N/A | 0 +100.00% | -31.3M +38.36% | -22.6M +113.64% | |
Total Nonoperating Income and Expense | -38.9M +27.59% | -30.5M +7.23% | -28.4M -4.12% | -29.6M +226.02% | |
Income before Taxes | -39.9M +136.24% | -16.9M -5.22% | -17.8M -51.25% | -36.6M +23.66% | |
Income Taxes | 28.2M +153.78% | 11.1M +84.11% | 6.0M -0.81% | 6.1M +11.45% | |
Extraordinary Items | 2.6M +531.64% | 411,629 0.00% | 411,629 -95.21% | 8.6M +180.51% | |
Net Income | -68.1M +143.20% | -28.0M +9.63% | -25.5M -39.83% | -42.5M +26.02% | |
Net Income from Continuing Operations Applicable to Common | -39.9M +136.24% | -16.9M -5.22% | -17.8M -51.25% | -36.6M +23.66% | |
Basic EPS and Net Income | -0.09 -43.75% | -0.16 -15.79% | -0.19 -42.42% | -0.33 +22.22% | |
Diluted EPS and Net Income | -0.09 -43.75% | -0.16 -15.79% | -0.19 -42.42% | -0.33 +22.22% | |
Basic Weighted Average Shares | 734.7M +307.30% | 180.4M +33.39% | 135.2M +5.55% | 128.1M +3.48% | |
Diluted Weighted Average Shares | 734.7M +307.30% | 180.4M +33.39% | 135.2M +5.55% | 128.1M +3.48% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 102.2M +11.60% | 91.6M +473.80% | 16.0M +5.38% | 15.1M -0.04% | |
Short-Term Investments | 1.0M N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 103.3M +12.71% | 91.6M +473.80% | 16.0M +5.38% | 15.1M -0.04% | |
Total Current Assets | 305.1M +32.44% | 230.4M +54.77% | 148.9M +218.55% | 46.7M +12.22% | |
Accumulated Depreciation | 28.3M +173.92% | 10.3M +13.45% | 9.1M -9.83% | 10.1M +31.13% | |
Property and Plant and Equipment and Net | 217.5M +573.15% | 32.3M +38.73% | 23.3M -74.01% | 89.6M -9.93% | |
Total Long-Term Assets | 7.0M -82.48% | 39.7M +70.58% | 23.3M -74.64% | 91.8M -15.04% | |
Total Assets | 817.2M +193.03% | 278.9M +52.16% | 183.3M +15.15% | 159.2M -4.68% | |
Income Taxes Payable | 10.2M +3,762.50% | 264,518 +21.03% | 218,563 -96.46% | 6.2M +18.66% | |
Total Short-Term Debt | 17.6M +1,854.44% | 900,000 -98.51% | 60.2M +411.21% | 11.8M +961.26% | |
Total Current Liabilities | 191.5M +41.38% | 135.5M -24.52% | 179.5M +504.09% | 29.7M +81.08% | |
Total Long-Term Debt | 136.2M +91.09% | 71.3M +28.73% | 55.4M +19.76% | 46.2M +69.22% | |
Total Long-Term Liabilities | 983,299 +2,537.75% | 37,278 -76.09% | 155,917 -99.66% | 46.2M +69.22% | |
Total Liabilities | 509.7M +128.27% | 223.3M +12.04% | 199.3M +27.99% | 155.7M +25.61% | |
Retained Earnings | -299.5M +29.43% | -231.4M +13.77% | -203.4M +14.36% | -177.9M +31.35% | |
Total Stockholders Equity | 307.4M +453.29% | 55.6M +446.33% | -16.0M -566.27% | 3.4M -92.00% | |
Total Shares Outstanding | 1.1B +212.95% | 337.8M +206.15% | 110.3M N/A | 0 -100.00% | |
Cash Flow | |||||
Cash from Operating Activities | 3.7M +136.26% | -10.2M +959.58% | -965,906 -94.66% | -18.1M -40.78% | |
Capital Expenditures | 28.3M +142.19% | 11.7M +135.64% | 5.0M -10.76% | 5.6M -69.18% | |
Cash from Investing Activities | 8.8M +207.71% | -8.1M +134.02% | -3.5M -38.13% | -5.6M -22.12% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 18.4M -80.41% | 94.0M +1,688.46% | 5.3M -77.81% | 23.7M -8.12% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | 47.17% N/A | |
Operating Margin | -0.39% -102.86% | 13.65% +13.69% | 12.00% +229.09% | -9.30% N/A | |
Return on Assets | -12.43% +2.54% | -12.12% -18.77% | -14.92% -42.69% | -26.04% N/A | |
Return on Equity | -37.53% -73.52% | -141.74% -134.96% | 405.42% +321.76% | -182.82% N/A | |
Revenue Growth | 170.43% +1,235.07% | 12.77% -29.47% | 18.10% -51.17% | 37.06% N/A | |
Current Ratio | 1.59 -6.33% | 1.70 +105.04% | 0.83 -47.27% | 1.57 N/A | |
Cash Ratio | 0.53 -21.06% | 0.68 +659.78% | 0.09 -82.55% | 0.51 N/A | |
Debt-to-Equity Ratio | 0.50 -61.49% | 1.30 +118.03% | -7.21 -142.73% | 16.86 N/A | |
Debt-to-Assets Ratio | 0.19 -27.27% | 0.26 -58.96% | 0.63 +73.01% | 0.36 N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow